TY - JOUR
T1 - Presence of clone-specific markers at birth in children with acute lymphoblastic leukaemia
AU - Hjalgrim, L L
AU - Madsen, H O
AU - Melbye, M
AU - Jørgensen, P
AU - Christiansen, M
AU - Andersen, M T
AU - Pallisgaard, N
AU - Hokland, P
AU - Clausen, N
AU - Ryder, L P
AU - Schmiegelow, K
AU - Hjalgrim, H
PY - 2002/10/21
Y1 - 2002/10/21
N2 - Recent studies have suggested that development of childhood acute lymphoblastic leukaemia may often be initiated in utero. To provide further evidence of an prenatal origin of childhood leukaemia, we conducted a molecular biological investigation of nine children with B-precursor acute lymphoblastic leukaemia carrying the chromosomal translocation t(12;21), the most common subtype of all childhood acute lymphoblastic leukaemia. Specifically, for each child we identified the non-constitutive chromosomal sequences made up by the t(12;21) fusion gene. From these, leukaemia clone-specific DNA primers were constructed and applied in nested polymerase chain reaction analyses of DNA extracted from the patients' Guthrie cards obtained at birth. Leukaemia clone-specific fusion gene regions were demonstrated in Guthrie card DNA of three patients, age 2 years 11 months, 3 years 4 months, and 5 years 8 months at leukaemia diagnosis. Our findings are consistent with previous observations, and thus provide further evidence that the development of t(12;21) B-precursor acute lymphoblastic leukaemia may be initiated in utero. Review of the current literature moreover indicates that age at leukaemia may be inversely correlated with the burden of cells with leukaemia clonal markers, i.e. leukaemia predisposed cells at birth, and that certain types of childhood acute lymphoblastic leukaemia develop as a multiple step process involving both pre- and postnatal genetic events.
AB - Recent studies have suggested that development of childhood acute lymphoblastic leukaemia may often be initiated in utero. To provide further evidence of an prenatal origin of childhood leukaemia, we conducted a molecular biological investigation of nine children with B-precursor acute lymphoblastic leukaemia carrying the chromosomal translocation t(12;21), the most common subtype of all childhood acute lymphoblastic leukaemia. Specifically, for each child we identified the non-constitutive chromosomal sequences made up by the t(12;21) fusion gene. From these, leukaemia clone-specific DNA primers were constructed and applied in nested polymerase chain reaction analyses of DNA extracted from the patients' Guthrie cards obtained at birth. Leukaemia clone-specific fusion gene regions were demonstrated in Guthrie card DNA of three patients, age 2 years 11 months, 3 years 4 months, and 5 years 8 months at leukaemia diagnosis. Our findings are consistent with previous observations, and thus provide further evidence that the development of t(12;21) B-precursor acute lymphoblastic leukaemia may be initiated in utero. Review of the current literature moreover indicates that age at leukaemia may be inversely correlated with the burden of cells with leukaemia clonal markers, i.e. leukaemia predisposed cells at birth, and that certain types of childhood acute lymphoblastic leukaemia develop as a multiple step process involving both pre- and postnatal genetic events.
KW - Adolescent
KW - Base Sequence
KW - Biomarkers, Tumor/genetics
KW - Blood Specimen Collection
KW - Child
KW - Child, Preschool
KW - Chromosomes, Human, Pair 12/genetics
KW - Chromosomes, Human, Pair 21/genetics
KW - Core Binding Factor Alpha 2 Subunit
KW - DNA Primers/chemistry
KW - DNA, Neoplasm/analysis
KW - Female
KW - Gene Rearrangement
KW - Genes, Immunoglobulin
KW - Genetic Predisposition to Disease
KW - Humans
KW - Infant
KW - Infant, Newborn
KW - Male
KW - Mannose-Binding Lectin/genetics
KW - Molecular Sequence Data
KW - Neoplasm Proteins/genetics
KW - Oncogene Proteins, Fusion/genetics
KW - Polymerase Chain Reaction
KW - Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/genetics
KW - Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics
KW - Translocation, Genetic/genetics
U2 - 10.1038/sj.bjc.6600601
DO - 10.1038/sj.bjc.6600601
M3 - Journal article
C2 - 12434291
SN - 0007-0920
VL - 87
SP - 994
EP - 999
JO - British Journal of Cancer
JF - British Journal of Cancer
IS - 9
ER -